Plain-English translation of NCT07243171 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is a clinical trial testing a new medication called ecnoglutide to see if it can help people with overweight or obesity. The study is checking whether the medication is safe, how your body processes it, and whether it helps with weight management. About 84 people in China will participate, with some receiving the medication and others receiving a placebo (a dummy pill).
Current weight management options don't work well enough for everyone, and doctors need new treatments to help people achieve and maintain a healthier weight. This trial will determine whether this medication could become a useful option for people struggling with overweight or obesity.
You likely qualify if…
You likely don't qualify if…
Depending on which group you join, you would either take a daily pill for 3–4 weeks, or a weekly pill for up to 24 weeks. You'll have regular visits where researchers check your health, take blood samples, and monitor how the medication affects your body. The study involves both the medication and a placebo group to make sure researchers can fairly compare results.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
China